Patents by Inventor Eline Dejonckheere

Eline Dejonckheere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MMP8 inactivating antigen binding proteins
    Patent number: 9828437
    Abstract: Described are MMP8 inactivating antigen binding proteins, such as antigen binding proteins comprising an amino acid sequence that comprises 4 framework regions and 3 complementary determining regions; further described is the use of such antigen binding proteins to treat inflammation, such as, but not limited to, systemic inflammatory response syndrome, sepsis, LPS induced inflammation, renal ischemia/reperfusion injury, ventilation induced lung injury, periodontal inflammation, rheumatoid arthritis, multiple sclerosis, ankylosing spondylitis, Lyme arthritis and osteoarthritis.
    Type: Grant
    Filed: November 2, 2011
    Date of Patent: November 28, 2017
    Assignees: VIB vzw, Universiteit Gent
    Inventors: Claude Libert, Eline Dejonckheere, Roosmarijn Vandenbroucke
  • MMP8 INACTIVATING ANTIGEN BINDING PROTEINS
    Publication number: 20140037646
    Abstract: Described are MMP8 inactivating antigen binding proteins, such as antigen binding proteins comprising an amino acid sequence that comprises 4 framework regions and 3 complementary determining regions; further described is the use of such antigen binding proteins to treat inflammation, such as, but not limited to, systemic inflammatory response syndrome, sepsis, LPS induced inflammation, renal ischemia/reperfusion injury, ventilation induced lung injury, periodontal inflammation, rheumatoid arthritis, multiple sclerosis, ankylosing spondylitis, Lyme arthritis and osteoarthritis.
    Type: Application
    Filed: November 2, 2011
    Publication date: February 6, 2014
    Applicants: UNIVERSITEIT GENT, VIB VZW
    Inventors: Claude Libert, Eline Dejonckheere